• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Antiresorptive agents-related osteonecrosis of the jaw (ARONJ) in rheumatoid arthritis.

作者信息

Fujieda Yuichiro, Atsumi Tatsuya

机构信息

Department of Rheumatology, Nephrology and Endocrinology, Faculty of Medicine, Hokkaido University, Kita 14, Nishi 5, Kita-ku, Sapporo, 060-8648, Japan.

出版信息

J Bone Miner Metab. 2020 Sep;38(5):739-741. doi: 10.1007/s00774-020-01112-2.

DOI:10.1007/s00774-020-01112-2
PMID:32591907
Abstract
摘要

相似文献

1
Antiresorptive agents-related osteonecrosis of the jaw (ARONJ) in rheumatoid arthritis.类风湿关节炎中抗吸收剂相关的颌骨坏死（ARONJ）
J Bone Miner Metab. 2020 Sep;38(5):739-741. doi: 10.1007/s00774-020-01112-2.
2
Incidence and risk of antiresorptive agent-related osteonecrosis of the jaw (ARONJ) after tooth extraction in patients with autoimmune disease.自身免疫性疾病患者拔牙后抗吸收剂相关颌骨坏死（ARONJ）的发生率和风险。
J Bone Miner Metab. 2020 Jul;38(4):581-588. doi: 10.1007/s00774-020-01089-y. Epub 2020 Feb 19.
3
High incidence of antiresorptive agent-related osteonecrosis of the jaw in patients with rheumatoid arthritis.类风湿关节炎患者中抗吸收剂相关颌骨坏死的高发病率。
J Bone Miner Metab. 2020 Sep;38(5):737-738. doi: 10.1007/s00774-020-01103-3. Epub 2020 Apr 9.
4
Antiresorptive Agent-Related Osteonecrosis of the Jaw (ARONJ): A Twist of Fate in the Bone.抗吸收剂相关颌骨骨坏死（ARONJ）：骨骼中的命运转折。
Tohoku J Exp Med. 2019 Feb;247(2):75-86. doi: 10.1620/tjem.247.75.
5
CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.抗吸收剂相关性颌骨坏死/药物相关性颌骨坏死的 CT 影像学特征。
Dentomaxillofac Radiol. 2018 May;47(4):20170323. doi: 10.1259/dmfr.20170323. Epub 2018 Feb 13.
6
Antiresorptive agent-related osteonecrosis of the jaw (ARONJ) in urological malignancies: a multi-center retrospective study.抗吸收剂相关的颌骨坏死 (ARONJ) 在泌尿系统恶性肿瘤中的应用：一项多中心回顾性研究。
J Bone Miner Metab. 2021 Jul;39(4):661-667. doi: 10.1007/s00774-021-01207-4. Epub 2021 Mar 11.
7
Relationships of opacification in the nasal sinuses, rhinosinusitis, and antiresorptive agent-related osteonecrosis of the jaw.鼻窦混浊、鼻窦炎和抗吸收剂相关性颌骨坏死之间的关系。
Auris Nasus Larynx. 2020 Dec;47(6):996-1002. doi: 10.1016/j.anl.2020.05.013. Epub 2020 Jun 24.
8
Denosumab, an Alternative to Bisphosphonates but also Associated with Osteonecrosis of the Jaw--What is the Risk?地诺单抗，双膦酸盐的替代品但也与颌骨坏死相关——风险是什么？
Dent Update. 2015 Jun;42(5):436-8, 440. doi: 10.12968/denu.2015.42.5.436.
9
Antiresorptive drug-related osteonecrosis of the jaw.抗吸收药物相关的颌骨坏死
Dent Clin North Am. 2014 Apr;58(2):369-84. doi: 10.1016/j.cden.2013.12.006.
10
[Use of a xenogeneic collagen matrix on extraction sockets: a new approach in ARONJ prevention (in german)].[在拔牙创中使用异种胶原基质：预防药物相关性颌骨坏死的一种新方法（德语）]
Swiss Dent J. 2020 Feb 10;130(2):139-145. doi: 10.61872/sdj-2020-02-02.

引用本文的文献

1
Treatment of Glucocorticoid-Induced Osteoporosis and Risk Factors for New Vertebral Fractures in Female Patients with Autoimmune Diseases.自身免疫性疾病女性患者糖皮质激素诱导的骨质疏松症的治疗及新发椎体骨折的危险因素
J Osteoporos. 2021 Oct 25;2021:5515653. doi: 10.1155/2021/5515653. eCollection 2021.
2
High incidence of antiresorptive agent-related osteonecrosis of the jaw in patients with rheumatoid arthritis.类风湿关节炎患者中抗吸收剂相关颌骨坏死的高发病率。
J Bone Miner Metab. 2020 Sep;38(5):737-738. doi: 10.1007/s00774-020-01103-3. Epub 2020 Apr 9.

本文引用的文献

1
Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer.长期地诺单抗治疗的安全性：两项针对转移性乳腺癌和前列腺癌患者的3期研究开放标签扩展阶段的结果
Support Care Cancer. 2016 Jan;24(1):447-455. doi: 10.1007/s00520-015-2904-5. Epub 2015 Sep 3.
2
Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases.颌骨骨坏死的发生率、风险因素和结局：三例有对照的 III 期临床试验对癌症伴骨转移患者的综合分析
Ann Oncol. 2012 May;23(5):1341-1347. doi: 10.1093/annonc/mdr435. Epub 2011 Oct 10.